European Archives - Page 777 of 1219 - European Medical Journal

Ability to Stabilise and Stockpile Covid-19 Vaccine is Vital

An incredible global effort is underway by companies and scientists digging deep to find a vaccine for Covid-19…

New COVID-19 Vaccine Candidate Generates Neutralising Antibodies

New COVID-19 Vaccine Candidate Generates Neutralising Antibodies

A VACCINE candidate for COVID-19 has shown promise in mice studies by producing antibodies specific to SARS-CoV-2, at levels thought to be sufficient…

Could Ivermectin be an Effective COVID-19 Treatment?

Could Ivermectin be an Effective COVID-19 Treatment?

IVERMECTIN, an antiparasitic drug that is in use around the world, has shown to kill the SARS-CoV-2 virus within 48 hours…

Erythroderma: A Manifestation of Cutaneous and Systemic Diseases

Erythroderma, or generalised exfoliative dermatitis, is a rare inflammatory disorder characterised by generalised erythema, involving more than 90%…

Second AACR International Meeting: Advances in Malignant Lymphoma

Second AACR International Meeting: Advances in Malignant Lymphoma: Maximizing the Basic-Translational Interface for Clinical Application held in…

EMJ: Ron Landmann interview at ICDS 2020

Speaking to us at the 2020 Israel International Colorectal Disease Symposium, Dr Ron Landmann, Chief of Division of Colorectal Surgery/Surgical Oncology…

Rheumatoid Arthritis Drug to be Repurposed for COVID-19 Therapy in Phase II/III Clinical Trial

The U.S. Department of Human Health and Services’ (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR)…

pandemic

COVID-19 Pandemic Knowledge Course

ES4P’s David Joyce, MD, MBA, and Scott Parazynski, MD, Partner to Offer New Course on Coronavirus Disease (COVID-19)…

Improving access in Africa

There are many notable initiatives in place by pharmaceutical companies to improve access to medicine around the world, especially in hard-to-reach and developing countries.

Johnson & Johnson Announces a Lead Vaccine Candidate for COVID-19

Johnson & Johnson Announces a Lead Vaccine Candidate for COVID-19; Landmark New Partnership with U.S…